P.J. Hengeveld will defend his dissertation on Wednesday 27 March 2024; getiteld: Molecular Risk Stratification in Chronic Lymphocytic Leukemia
- Promotor
- Co-promotor
- Co-promotor
- Date
- Wednesday 27 Mar 2024, 15:30 - 17:00
- Type
- PhD defence
- Space
- Professor Andries Querido room
- Building
- Education Center
- Location
- Erasmus MC
Below is a brief summary of the dissertation:
Chronic lymphocytic leukemia (CLL) is a type of blood cancer characterized by the accumulation of monoclonal, mature B cells. CLL is well known for its clinical heterogeneity: while some patients need therapy at the moment of diagnosis, others may go years or even decades without treatment. In addition, while generally responding well to treatment, the duration of remission in CLL is highly variable. In this thesis, I have used several molecular techniques to better characterize this heterogeneity, in order to achieve more accurate prognostic stratification of CLL patients before, during and after treatment. Chronische lymfa.
- More information
The public defence will start exactly at 15.30pm. The doors will be closed once the public defence starts, latecomers can access the hall via the fourth floor. Given the solemn nature of the meeting, we advise not to bring children under the age of 6 to the first part of the ceremony.
A livestream link has been provided to candidate.
